Literature DB >> 8306991

Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis.

K Sorimachi1, D J Craik.   

Abstract

Amyloid deposition is a biochemical and histopathologic hallmark of various clinical forms of amyloidoses including Alzheimer's disease and the Dutch-type hereditary cerebral haemorrhage with amyloidosis. The self-aggregating peptides responsible for these irreversible deposits have been sequenced but the mechanisms involved in the aggregation processes are not well understood. In order to gain an understanding of the possible structures prior to self-association, the extracellular fragment of the Alzheimer amyloid protein (beta A4) responsible for the deposits (the 'native' fragment) and a mutant of this with a single residue substitution (which is responsible for deposits in the Dutch-type amyloidosis) were examined by 1H-NMR spectroscopy. Interproton distance constraints were derived from NMR experimental data and incorporated into tertiary structure calculations using a simulated annealing protocol. Solution conformations of the fragment peptides associated with the two forms of amyloidoses are presented and compared. Although in both peptides the existence of a mixture of conformations in equilibrium is likely, one such population of structures possesses a flexible N-terminus and a well defined C-terminal region. The latter region includes a helical segment and a terminal turn-like structure. These structural features may be important for the basis of amyloid formation. Comparison of the calculated structures of the two peptides revealed a conformationally different region arising from the conservative substitution of Gln22 for Glu22. This region may be responsible for altered binding in the mutant peptide, giving rise to the clinically different form of amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306991     DOI: 10.1111/j.1432-1033.1994.tb19935.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Structure of A beta(25-35) peptide in different environments.

Authors:  Ganesh Shanmugam; Prasad L Polavarapu
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

2.  The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis.

Authors:  C Soto; E M Castaño
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

3.  Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide.

Authors:  P H Jensen; E S Sørensen; T E Petersen; J Gliemann; L K Rasmussen
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

4.  Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)].

Authors:  O M El-Agnaf; G B Irvine; G Fitzpatrick; W K Glass; D J Guthrie
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

5.  Solvent effects on self-assembly of beta-amyloid peptide.

Authors:  C L Shen; R M Murphy
Journal:  Biophys J       Date:  1995-08       Impact factor: 4.033

6.  The solution structure of rat Abeta-(1-28) and its interaction with zinc ion: insights into the scarcity of amyloid deposition in aged rat brain.

Authors:  Jin Huang; Yong Yao; Jun Lin; Yong-Hao Ye; Wei-Yin Sun; Wen-Xia Tang Dagger
Journal:  J Biol Inorg Chem       Date:  2004-05-25       Impact factor: 3.358

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.